Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP CHAGAS: Posaconazole for Chagas Disease
NCT01377480Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of posaconazole in Chagas disease, sponsored by Merck & Co.. Started Jul 2011; status: completed.
02
Drugs
posaconazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT01377480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377480.